Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage

Stroke

Volumn 38, Issue 2, 2007, Pages 337-342

  Girot, Marie ^a   Ferro, José M ^b   Canhão, Patrícia ^b   Stam, Jan ^c   Bousser, Marie Germaine ^d   Barinagarrementeria, Fernando ^e   Leys, Didier ^a,f  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d HÔPITAL LARIBOISIÈRE   (France)

^e NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^f UNIV LILLE   (France)

Author keywords

Acute stroke; Cerebral venous thrombosis; Intracerebral hemorrhage

Indexed keywords

ANTITHROMBOCYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; EVALUATION; FEMALE; GENDER; GROUPS BY AGE; HUMAN; LATERAL SINUS THROMBOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOTOR DYSFUNCTION; OCCLUSIVE CEREBROVASCULAR DISEASE; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; RISK ASSESSMENT; SEX RATIO;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CEREBRAL HEMORRHAGE; CEREBRAL VEINS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 33846606852     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000254579.16319.35     Document Type: Article

References (18)

1. Breteau G, Mounier-Vehier F, Godefroy O, Gauvrit JY, Mackowiak-Cordoliani MA, Girot M, Bertheloot D, Henon H, Lucas C, Leclerc X, Fourrier F, Pruvo JP, Leys D. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol. 2003;250:29-35.
2. Ferro JM, Correia M, Pontes C, Baptista MV, Pita F, Cerebral Venous Thrombosis Portuguese Collaborative Study Group (Venoport). Cerebral vein and dural sinus thrombosis in Portugal: 1980-1998. Cerebrovasc Dis. 2001;11:177-182.
3. Ferro JM, Madureira S. Age-related white matter changes and cognitive impairment. J Neurol Sci. 2002;203-204:221-225.
4. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;35:664-670.
5. Bousser MG. Cerebral venous thrombosis: diagnosis and management. J Neurol. 2000;247:252-258.
6. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke. 1988;19:1497-1500.
7. Candelise L, Pinardi G, Aritzu E, Musicco M. Telephone interview for stroke outcome assessment. Cerebrovasc Dis. 1994;4:341-343.
8. Glantz S, Slinker B. Primer of applied regression and analysis of variance. New York: McGraw Hill; 1990.
9. Bendel R, Afifi A. Comparison of stopping rules in forward regression. J Am Stat Ass. 1977;72:46-53.
10. Biousse V, Tong F, Newman NJ. Cerebral Venous Thrombosis. Curr Treat Options Neurol. 2003;5:409-420.
11. Mehraein S, Schmidtke K, Villringer A, Valdueza JM, Masuhr F. Heparin treatment in cerebral sinus and venous thrombosis: patients at risk of fatal outcome. Cerebrovasc Dis. 2003;15:17-21.
12. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. For The Cerebral Venous Sinus Thrombosis Study Group. J Neurol Neurosurg Psychiatry. 2001;70:105-108.
13. Cakmak S, Derex L, Berruyer M, Nighoghossian N, Philippeau F, Adeleine P, Hermier M, Froment JC, Trouillas P. Cerebral venous thrombosis: clinical outcome and systematic screening of prothrombotic factors. Neurology. 2003;60:1175-1178.
14. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J. Cerebral Venous Thrombosis Portugese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis. results of the VENOPORT study. Cerebrovasc Dis. 2002;13:272-278.
15. Newton TH, Potts DG. Radiology of the skull and brain/angiography; vol. II Book II Veins. St Louis, MO: Mosby; 1974.
16. Fink JN, McAuley DL. Safety of anticoagulation for cerebral venous thrombosis associated with intracerebral hematoma. Neurology. 2001;57:1138-1139.
17. Curtin KR, Shaibani A, Resnick SA, Russell EJ, Simuni T. Rheolytic catheter thrombectomy, balloon angioplasty, and direct recombinant tissue plasminogen activator thrombolysis of dural sinus thrombosis with preexisting hemorrhagic infarctions. AJNR Am J Neuroradiol. 2004;25:1807-1811.
18. Kimura R, Nakase H, Tamaki R, Sakaki T. Vascular endothelial growth factor antagonist reduces brain edema formation and venous infarction. Stroke. 2005;36:1259-1263.